Temasek Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,372,712
| Closed | -$200M | – | 53 |
|
|
2020
Q1 | $200M | Hold |
2,372,712
| – | – | 1.48% | 14 |
|
|
2019
Q4 | $201M | Hold |
2,372,712
| – | – | 1.31% | 14 |
|
|
2019
Q3 | $160M | Hold |
2,372,712
| – | – | 1.17% | 16 |
|
|
2019
Q2 | $203M | Hold |
2,372,712
| – | – | 1.45% | 16 |
|
|
2019
Q1 | $211M | Hold |
2,372,712
| – | – | 1.46% | 18 |
|
|
2018
Q4 | $202M | Hold |
2,372,712
| – | – | 1.39% | 17 |
|
|
2018
Q3 | $230M | Sell |
2,372,712
-1,100,000
| -32% | -$107M | 1.34% | 17 |
|
|
2018
Q2 | $327M | Hold |
3,472,712
| – | – | 1.72% | 13 |
|
|
2018
Q1 | $282M | Hold |
3,472,712
| – | – | 1.54% | 15 |
|
|
2017
Q4 | $310M | Hold |
3,472,712
| – | – | 1.9% | 11 |
|
|
2017
Q3 | $323M | Hold |
3,472,712
| – | – | 1.88% | 10 |
|
|
2017
Q2 | $315M | Hold |
3,472,712
| – | – | 2.03% | 6 |
|
|
2017
Q1 | $305M | Hold |
3,472,712
| – | – | 2.27% | 6 |
|
|
2016
Q4 | $288M | Hold |
3,472,712
| – | – | 2.3% | 7 |
|
|
2016
Q3 | $321M | Hold |
3,472,712
| – | – | 2.6% | 7 |
|
|
2016
Q2 | $270M | Hold |
3,472,712
| – | – | 2.11% | 8 |
|
|
2016
Q1 | $286M | Hold |
3,472,712
| – | – | 2.26% | 8 |
|
|
2015
Q4 | $364M | Buy |
3,472,712
+888,545
| +34% | +$93.1M | 2.76% | 7 |
|
|
2015
Q3 | $272M | Hold |
2,584,167
| – | – | 2.58% | 10 |
|
|
2015
Q2 | $353M | Buy |
2,584,167
+621,755
| +32% | +$85M | 2.21% | 8 |
|
|
2015
Q1 | $245M | Sell |
1,962,412
-170,366
| -8% | -$21.2M | 1.83% | 9 |
|
|
2014
Q4 | $193M | Hold |
2,132,778
| – | – | 2% | 12 |
|
|
2014
Q3 | $154M | Hold |
2,132,778
| – | – | 1.64% | 11 |
|
|
2014
Q2 | $133M | Buy |
2,132,778
+580,924
| +37% | +$36.1M | 1.99% | 9 |
|
|
2014
Q1 | $106M | Buy |
+1,551,854
| New | +$106M | 1.64% | 10 |
|